Respiri Limited (RSH.AX)
AUD 0.07
(-4.0%)
AUD 0.07
(-4.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 456.91 Thousand AUD | 118.52% |
| 2023 | -2.44 Million AUD | -28.97% |
| 2022 | -1.89 Million AUD | 16.06% |
| 2021 | -2.25 Million AUD | -205.35% |
| 2020 | 2.14 Million AUD | 109.95% |
| 2019 | 1.02 Million AUD | 38.81% |
| 2018 | 736 Thousand AUD | 38.7% |
| 2017 | 530.63 Thousand AUD | 177.33% |
| 2016 | -686.17 Thousand AUD | -830.07% |
| 2015 | 93.98 Thousand AUD | 395.33% |
| 2014 | 18.97 Thousand AUD | 113.35% |
| 2013 | -142.13 Thousand AUD | -544.06% |
| 2012 | 32 Thousand AUD | -65.33% |
| 2011 | 92.31 Thousand AUD | 17.44% |
| 2010 | 78.6 Thousand AUD | 213.07% |
| 2009 | -69.52 Thousand AUD | -169.39% |
| 2008 | 100.19 Thousand AUD | -69.26% |
| 2007 | 325.94 Thousand AUD | 870.91% |
| 2006 | 33.57 Thousand AUD | -35.33% |
| 2005 | 51.91 Thousand AUD | 0.0% |
| 2004 | - AUD | 100.0% |
| 2003 | -178.66 Thousand AUD | 92.96% |
| 2002 | -2.53 Million AUD | 99.95% |
| 2001 | -4.76 Billion AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | -100.0% |
| 1997 | 1.74 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -1.95 Million AUD | 0.0% |
| 2024 FY | -455.18 Thousand AUD | 81.39% |
| 2024 Q4 | 309.24 Thousand AUD | 0.0% |
| 2023 Q2 | -1.19 Million AUD | 0.0% |
| 2023 Q4 | -1.25 Million AUD | 0.0% |
| 2023 FY | -2.44 Million AUD | -28.97% |
| 2022 Q2 | -818.77 Thousand AUD | 0.0% |
| 2022 FY | -1.89 Million AUD | 16.06% |
| 2022 Q4 | -901.43 Thousand AUD | 0.0% |
| 2021 Q4 | -1.12 Million AUD | 0.0% |
| 2021 Q2 | -1.13 Million AUD | 0.0% |
| 2021 FY | -2.25 Million AUD | -205.35% |
| 2020 FY | 2.14 Million AUD | 109.95% |
| 2020 Q2 | 2.15 Million AUD | 0.0% |
| 2020 Q4 | -7968.00 AUD | 0.0% |
| 2019 FY | 1.02 Million AUD | 38.81% |
| 2019 Q4 | -1966.00 AUD | 0.0% |
| 2019 Q2 | 1.02 Million AUD | 0.0% |
| 2018 FY | 736 Thousand AUD | 38.7% |
| 2018 Q2 | 865.15 Thousand AUD | 0.0% |
| 2018 Q4 | -3699.00 AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q4 | 825.6 Thousand AUD | 0.0% |
| 2017 FY | 530.63 Thousand AUD | 177.33% |
| 2016 Q4 | 249.74 Thousand AUD | 0.0% |
| 2016 Q2 | -935.92 Thousand AUD | 0.0% |
| 2016 FY | -686.17 Thousand AUD | -830.07% |
| 2015 Q4 | 93.49 Thousand AUD | 0.0% |
| 2015 FY | 93.98 Thousand AUD | 395.33% |
| 2015 Q2 | 495.00 AUD | 0.0% |
| 2014 Q2 | 6039.00 AUD | 0.0% |
| 2014 FY | 18.97 Thousand AUD | 113.35% |
| 2014 Q4 | 358.00 AUD | 0.0% |
| 2013 Q2 | -71.51 Thousand AUD | -7033.57% |
| 2013 Q1 | -1002.50 AUD | 0.0% |
| 2013 FY | -142.13 Thousand AUD | -544.06% |
| 2013 Q4 | 289.43 Thousand AUD | 10561.39% |
| 2013 Q3 | 2714.75 AUD | 103.8% |
| 2012 Q4 | - AUD | 100.0% |
| 2012 FY | 32 Thousand AUD | -65.33% |
| 2012 Q2 | -1002.50 AUD | -104.34% |
| 2012 Q3 | -1002.50 AUD | 0.0% |
| 2012 Q1 | 23.07 Thousand AUD | 0.0% |
| 2011 Q2 | 23.07 Thousand AUD | 17.44% |
| 2011 Q1 | 19.65 Thousand AUD | 0.0% |
| 2011 FY | 92.31 Thousand AUD | 17.44% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 Q3 | 23.07 Thousand AUD | 0.0% |
| 2010 Q4 | - AUD | -100.0% |
| 2010 Q3 | 19.65 Thousand AUD | -0.01% |
| 2010 Q1 | -17.38 Thousand AUD | 0.0% |
| 2010 Q2 | 19.65 Thousand AUD | 213.07% |
| 2010 FY | 78.6 Thousand AUD | 213.07% |
| 2009 Q3 | -17.38 Thousand AUD | -0.0% |
| 2009 Q2 | -17.38 Thousand AUD | -169.39% |
| 2009 Q4 | - AUD | 100.0% |
| 2009 FY | -69.52 Thousand AUD | -169.39% |
| 2009 Q1 | 25.04 Thousand AUD | 0.0% |
| 2008 Q2 | 25.04 Thousand AUD | -32.83% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 FY | 100.19 Thousand AUD | -69.26% |
| 2008 Q1 | 37.28 Thousand AUD | 0.0% |
| 2008 Q3 | 25.04 Thousand AUD | 0.0% |
| 2007 Q1 | 8392.75 AUD | 0.0% |
| 2007 FY | 325.94 Thousand AUD | 870.91% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 Q3 | 37.28 Thousand AUD | 0.0% |
| 2007 Q2 | 37.28 Thousand AUD | 344.3% |
| 2006 Q3 | 8392.75 AUD | 0.0% |
| 2006 Q2 | 8392.75 AUD | -35.33% |
| 2006 FY | 33.57 Thousand AUD | -35.33% |
| 2006 Q4 | - AUD | -100.0% |
| 2006 Q1 | 12.97 Thousand AUD | 0.0% |
| 2005 FY | 51.91 Thousand AUD | 0.0% |
| 2005 Q3 | 12.97 Thousand AUD | 0.0% |
| 2005 Q2 | 12.97 Thousand AUD | 0.0% |
| 2005 Q1 | - AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2004 Q1 | -142.12 Thousand AUD | 0.0% |
| 2004 Q2 | - AUD | 100.0% |
| 2004 Q3 | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 FY | - AUD | 100.0% |
| 2003 Q4 | - AUD | 100.0% |
| 2003 Q1 | -415.72 Thousand AUD | 0.0% |
| 2003 Q2 | -142.12 Thousand AUD | 65.81% |
| 2003 Q3 | -142.12 Thousand AUD | -0.0% |
| 2003 FY | -178.66 Thousand AUD | 92.96% |
| 2002 Q3 | -415.72 Thousand AUD | 0.0% |
| 2002 Q1 | -1.19 Billion AUD | 0.0% |
| 2002 Q4 | - AUD | 100.0% |
| 2002 Q2 | -415.72 Thousand AUD | 99.97% |
| 2002 FY | -2.53 Million AUD | 99.95% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 Q4 | - AUD | 100.0% |
| 2001 Q3 | -1.19 Billion AUD | 0.0% |
| 2001 Q2 | -1.19 Billion AUD | 0.0% |
| 2001 FY | -4.76 Billion AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 FY | - AUD | -100.0% |
| 1998 Q1 | 435.47 Thousand AUD | 0.0% |
| 1998 Q2 | - AUD | -100.0% |
| 1997 FY | 1.74 Million AUD | 0.0% |
| 1997 Q4 | 435.47 Thousand AUD | 0.0% |
| 1997 Q2 | 435.47 Thousand AUD | 0.0% |
| 1997 Q3 | 435.47 Thousand AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| 4DMedical Limited | 3.51 Million AUD | 87.01% |
| Adherium Limited | -640.83 Thousand AUD | 171.3% |
| Aroa Biosurgery Limited | 53.98 Million AUD | 99.154% |
| Atomo Diagnostics Limited | 1.43 Million AUD | 68.197% |
| Anteris Technologies Ltd | 2.51 Million AUD | 81.848% |
| Control Bionics Limited | 3.67 Million AUD | 87.559% |
| CardieX Limited | 10.1 Million AUD | 95.48% |
| Compumedics Limited | 26.06 Million AUD | 98.247% |
| Cochlear Limited | 1.69 Billion AUD | 99.973% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 95.978% |
| Cyclopharm Limited | 4.49 Million AUD | 89.84% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 95.927% |
| Nova Eye Medical Limited | 20.19 Million AUD | 97.737% |
| HeraMED Limited | -504.09 Thousand AUD | 190.64% |
| Imricor Medical Systems, Inc. | -1.99 Million AUD | 122.927% |
| ImpediMed Limited | 9 Million AUD | 94.926% |
| InhaleRx Limited | 1.2 Million AUD | 62.052% |
| LBT Innovations Limited | -2.91 Million AUD | 115.664% |
| Micro-X Limited | 5.73 Million AUD | 92.036% |
| Neurotech International Limited | -5867.00 AUD | 7887.864% |
| OncoSil Medical Limited | 55.63 Thousand AUD | -721.315% |
| PolyNovo Limited | 36.08 Million AUD | 98.734% |
| SomnoMed Limited | 55.13 Million AUD | 99.171% |
| Universal Biosensors, Inc. | 4.28 Million AUD | 89.337% |
| Uscom Limited | 3.11 Million AUD | 85.335% |
| Visioneering Technologies, Inc. | -271.11 Thousand AUD | 268.531% |